x 

0 Activities
0 Activities
Notice: This activity is not available for credit.

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

Array

Activity Info

Upon completion of the activity, participants should be able to explain the circumstances – and rationale – under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar.
2. Explain the circumstances under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar
Email

CME/CE credit is no longer available for this activity.

Tags

Webinar | Gastroenterology | Internal Medicine | Family Medicine | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist | Not Available for Credit | 

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA